Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Sodium Lauryl Sulfate on Fexofenadine Absorption
NCT04534153Phase 1Completed
- Sponsor
- University of California, San Francisco
- Start
- Jan 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of fexofenadine in allergic rhinitis (AR) and urticaria (3 arms), sponsored by University of California, San Francisco. Primary endpoints: Area under the plasma concentration versus time curve and Maximum Plasma Concentration. Started Jan 2023; status: completed.
02
Drugs
fexofenadine
03
Conditions
allergic rhinitis (AR)urticaria
Beyond the preview
Go deeper on NCT04534153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04534153.